估计一种实验性抗癌治疗与对照之间生存获益的95%置信区间。 - Suppr

Suppr

超能文献

Estimating the 95% confidence interval for survival gain between an experimental anti-cancer treatment and a control.

作者信息

Messori Andrea, Caccese Erminia, D'Avella Maria Claudia

机构信息

HTA Unit, ESTAR Toscana, Regional Health System, via San Salvi 12, 50100 Florence, Italy.

HTA Unit, ESTAR Toscana, Regional Health System, Florence, Italy.

出版信息

Ther Adv Med Oncol. 2017 Nov;9(11):721-723. doi: 10.1177/1758834017731084. Epub 2017 Sep 18.

DOI:10.1177/1758834017731084

PMID:29344108

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5764153/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3649/5764153/2403f5162715/10.1177_1758834017731084-fig1.jpg

相似文献

Estimating the 95% confidence interval for survival gain between an experimental anti-cancer treatment and a control.估计一种实验性抗癌治疗与对照之间生存获益的95%置信区间。

Ther Adv Med Oncol. 2017 Nov;9(11):721-723. doi: 10.1177/1758834017731084. Epub 2017 Sep 18.

Association between gestational weight gain and perinatal outcomes in women with chronic hypertension.慢性高血压女性孕期体重增加与围产期结局的关联

Am J Obstet Gynecol. 2017 Sep;217(3):348.e1-348.e9. doi: 10.1016/j.ajog.2017.05.016. Epub 2017 May 15.

Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis.二甲双胍可改善 2 型糖尿病肺癌患者的生存：一项荟萃分析。

Med Clin (Barc). 2019 Apr 18;152(8):291-297. doi: 10.1016/j.medcli.2018.06.026. Epub 2018 Aug 30.

Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients.晚期非鳞状非小细胞肺癌患者治疗期间疗效结局与体重增加的关系。

Ann Oncol. 2016 Aug;27(8):1612-9. doi: 10.1093/annonc/mdw211. Epub 2016 May 23.

Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.查尔森合并症指数作为非小细胞肺癌手术后长期预后的预测指标。

Eur J Cardiothorac Surg. 2005 Nov;28(5):759-62. doi: 10.1016/j.ejcts.2005.06.046. Epub 2005 Sep 12.

Survival implications of time to surgical treatment of endometrial cancers.子宫内膜癌手术治疗时间对生存的影响。

Am J Obstet Gynecol. 2017 Mar;216(3):268.e1-268.e18. doi: 10.1016/j.ajog.2016.11.1050. Epub 2016 Dec 9.

The prevalence of human papillomavirus type 58 in Chinese patients with cervical carcinoma and its influence on survival.中国宫颈癌患者中 HPV58 型的流行情况及其对生存的影响。

Clin Oncol (R Coll Radiol). 2009 Dec;21(10):768-74. doi: 10.1016/j.clon.2009.09.003. Epub 2009 Oct 28.

Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis.辅助治疗和绝经的开始预示着乳腺癌诊断后的体重增加。

J Clin Oncol. 1999 Jan;17(1):120-9. doi: 10.1200/JCO.1999.17.1.120.

Interstage Weight Gain Is Associated With Survival After First-Stage Single-Ventricle Palliation.一期单心室姑息治疗后的过渡期体重增加与生存相关。

Ann Thorac Surg. 2017 Aug;104(2):674-680. doi: 10.1016/j.athoracsur.2016.12.031. Epub 2017 Mar 24.

Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients.赛庚啶显著提高了索拉非尼治疗的晚期肝癌患者的总生存期和无进展生存期。

Jpn J Clin Oncol. 2015 Apr;45(4):336-42. doi: 10.1093/jjco/hyv007. Epub 2015 Feb 2.

引用本文的文献

Outcomes at 5 years in patients with severe aortic stenosis: reviewing current information using the restricted mean survival time.重度主动脉瓣狭窄患者5年的预后：使用受限平均生存时间回顾当前信息。

Am J Cardiovasc Dis. 2020 Aug 15;10(3):136-141. eCollection 2020.

本文引用的文献

Value-Based Cancer Care.基于价值的癌症护理。

N Engl J Med. 2015 Dec 31;373(27):2593-5. doi: 10.1056/NEJMp1508387. Epub 2015 Nov 18.

Improved curve fits to summary survival data: application to economic evaluation of health technologies.改进的汇总生存数据曲线拟合：在卫生技术经济评价中的应用。

BMC Med Res Methodol. 2011 Oct 10;11:139. doi: 10.1186/1471-2288-11-139.

Survival time outcomes in randomized, controlled trials and meta-analyses: the parallel universes of efficacy and cost-effectiveness.随机对照试验和荟萃分析中的生存时间结局：疗效和成本效益的平行宇宙。

Value Health. 2011 Jul-Aug;14(5):640-6. doi: 10.1016/j.jval.2011.01.008. Epub 2011 May 31.

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.GRADE：关于证据质量评级和推荐强度的新共识。

BMJ. 2008 Apr 26;336(7650):924-6. doi: 10.1136/bmj.39489.470347.AD.

Gains in life expectancy from medical interventions--standardizing data on outcomes.医疗干预带来的预期寿命增长——对结果数据进行标准化处理

N Engl J Med. 1998 Aug 6;339(6):380-6. doi: 10.1056/NEJM199808063390606.

Median versus mean lifetime survival in the analysis of survival data.生存数据分析中的中位生存期与平均生存期对比

Haematologica. 1997 Nov-Dec;82(6):730.

Survival curve fitting using the Gompertz function: a methodology for conducting cost-effectiveness analyses on mortality data.

Comput Methods Programs Biomed. 1997 Mar;52(3):157-64. doi: 10.1016/s0169-2607(96)01788-9.

Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma. A lifetime cost-effectiveness analysis.紫杉醇作为晚期卵巢癌患者一线治疗药物的药物经济学概况。一项终生成本效益分析。

Cancer. 1996 Dec 1;78(11):2366-73.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验